Compare ARK Genomic Revolution ETF (ARKG) vs Invesco Galaxy Bitcoin ETF (BTCO) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Invesco Galaxy Bitcoin ETF — how do they compare? ARK Genomic Revolution ETF trades at $40.83, while Invesco Galaxy Bitcoin ETF trades at $63.56. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Invesco Galaxy Bitcoin ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | BTCO | |
|---|---|---|
Sector | Sector/Thematic | Crypto-linked |
52-Week High | $43.57 | $125.14 |
52-Week Low | $23.09 | $58.40 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
BTCO trades at $63.56, up 1.05% today, but technical indicators signal a bearish trend with moving averages and ADX pointing lower. Key financial ratios including P/E, P/S, and ROE are unavailable, limiting fundamental assessment. The stock faces resistance near $64 and support at $61.
The outlook remains cautious due to weak technical momentum and lack of fundamental data. Risks include market volatility and competitive pressures. Investors should await earnings reports for clarity on profitability and growth prospects before considering a position.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Invesco Galaxy Bitcoin ETF
BTCO is a spot Bitcoin ETF that tracks the price of Bitcoin directly. It offers investors a regulated and convenient way to gain exposure to the digital currency through a traditional brokerage account without holding the asset.
Read more on BTCO →
